Isoflurane Promotes Neuroinflammation and Induces Cognitive Impairment Through the miR-3099-5p/AQP4 Axis

Xiangshuo Meng1, Pengzhou Tang2, Shengquan Cheng3

  • 1Department of Anesthesiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Nanjing Medical University, Wuxi, Jiangsu, China.

Synapse (New York, N.Y.)
|September 29, 2025
PubMed
Abstract

Insights

Isoflurane anesthesia can impair cognitive function by increasing miR-3099-5p, which targets AQP4. Inhibiting miR-3099-5p protects against isoflurane-induced neurotoxicity and cognitive deficits.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Molecular Biology

Background:

  • Isoflurane is a common inhalational anesthetic with incompletely understood neurotoxic effects.
  • MicroRNA-3099-5p (miR-3099-5p) is implicated in neural injury, development, and differentiation.

Purpose of the Study:

  • To investigate the role of miR-3099-5p in isoflurane-induced neurotoxicity.
  • To elucidate the underlying molecular mechanisms, including AQP4 regulation.

Main Methods:

  • Utilized an isoflurane-treated Sprague-Dawley rat model.
  • Assessed cognitive function using the Morris water maze.
  • Measured inflammatory factors (ELISA), oxidative stress (TBARS, WST-1/NBT), and gene expression (qRT-PCR).
  • Investigated gene regulation via dual-luciferase reporter assays.

Main Results:

  • Isoflurane exposure impaired spatial learning and memory in rats.
  • miR-3099-5p expression was upregulated following isoflurane exposure.
  • Inhibiting miR-3099-5p ameliorated cognitive deficits, neuroinflammation, and oxidative stress.
  • This protective effect was mediated by direct targeting and inhibition of Aquaporin-4 (AQP4) expression.

Conclusions:

  • miR-3099-5p plays a critical role in mediating isoflurane-induced neurotoxicity through AQP4 regulation.
  • Inhibition of miR-3099-5p offers a potential therapeutic strategy for mitigating anesthesia-related neural damage.
  • This finding opens avenues for developing neuroprotective drugs against anesthesia-induced cognitive impairment.